Current options for vaccine delivery systems by mucosal routes
- 1 October 1997
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 48 (2-3), 243-257
- https://doi.org/10.1016/s0168-3659(97)00036-9
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- Construction and oral immunogenicity of a Salmonella typhimurium strain expressing a streptococcal adhesin linked to the
A 2B Vaccine, 1996 - Liposomes and ISCOMS as vaccine formulationsBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1995
- Induction of a secretory IgA response in the murine female urogenital tract by immunization of the lungs with liposome-supplemented viral subunit antigenVaccine, 1995
- Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral ProteinScience, 1993
- Persistence of plasmid DNA and expression in rat brain cells in vivoExperimental Neurology, 1992
- Oral Delivery of VaccinesClinical Pharmacokinetics, 1992
- Strong expression of foreign genes following direct injection into fish muscleFEBS Letters, 1991
- Targeting and controlled release of antigens for the effective induction of secretory antibody responsesCurrent Opinion in Immunology, 1991
- Glycoproteins of Human Parainfluenza Virus Type 3: Affinity Purification, Antigenic Characterization and Reconstitution into Lipid VesiclesJournal of General Virology, 1987
- IgA COMMITMENT: MODELS FOR B‐CELL DIFFERENTIATION AND POSSIBLE ROLES FOR T‐CELLS IN REGULATING B‐CELL DEVELOPMENT*Annals of the New York Academy of Sciences, 1983